logo

For the Inventor, By the Inventor

Maplehurst, near Horsham, undefined

Harry Smith

USPTO Granted Patents = 35

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 193(Granted Patents)


Location History:

  • Maplehurst, near Horsham, EN (1976 - 1977)
  • Maplehurst near Horsham, EN (1977)
  • Maplehurst, EN (1977)
  • Horsham, EN (1977)
  • Maplehurst, GB (1981)
  • Maplehurst, near Horsham, GB (1980 - 1983)
  • Maplehurst Nr. Horsham, GB (1980 - 1983)
  • Maplehurst, Nr Horsham, GB (1984)
  • Maplehurst Nr Horsham, GB (1984)
  • Maplehurst, Nr. Horsham, GB (1979 - 1988)
  • Epsom, GB (1998 - 2003)

Company Filing History:

goldMedal34 out of 855 
 
Beecham Group Plc
 patents
silverMedal1 out of 2,198 
 
Smithkline Beecham Corporation
 patents

Years Active: 1976-2003

Loading Chart...
35 patents (USPTO):Explore Patents
1. 6531600 - Treatment and compounds (2003-03-11),
2. 6180791 - Synthesis of 8-substituted xanthines (2001-01-30),
3. 5981535 - Substituted xanthines and their use in the treatment of cerebrovascular (1999-11-09),
4. 5734051 - 8-substituted xanthine derivatives and method of use thereof (1998-03-31),
5. 4769383 - Dioxonaphthotriazoles having antiallergic activity (1988-09-06),
6. 4454136 - Substituted benzopyranotriazoles and antiallergic use (1984-06-12),
7. 4427686 - Pharmacologically active benzopyranotriazole compounds (1984-01-24),
8. 4405620 - Piperazine derivatives (1983-09-20),
9. 4378360 - 6-{3-[4-(Substituted (1983-03-29),
10. 4263309 - Polycyclic triazoles used to inhibit allergic responses (1981-04-21),
11. 4263299 - Heterocyclic coumarin derivatives (1981-04-21),
12. 4248879 - Benzopyranotriazoles (1981-02-03),
13. 4223032 - Triazolo [4,5-b] quinolines and prophylaxis of allergic diseases with (1980-09-16),
14. 4211791 - Indanediones (1980-07-08),
15. 4207335 - Indan-1,3-diones (1980-06-10),

Title: The Innovative Journey of Harry Smith

Introduction

Harry Smith, residing in Maplehurst near Horsham, England, is a notable inventor with an impressive portfolio of 35 patents. His work primarily focuses on medical treatments, showcasing his commitment to advancing healthcare through innovative solutions.

Latest Patents

Among his latest achievements are groundbreaking patents related to the treatment of cerebrovascular disorders. One of his key inventions is the synthesis of 8-substituted xanthines, which provides a method for effectively treating cerebrovascular disorders and/or disorders associated with cerebral senility. This method utilizes the administration of non-toxic amounts of a specific compound, demonstrating significant potential in the medical field.

Career Highlights

Harry Smith has had a distinguished career, having worked with prominent companies such as Beecham Group Plc and SmithKline Beecham Corporation. His roles in these organizations have allowed him to contribute significantly to research and development, focusing on pharmaceutical innovations.

Collaborations

Throughout his career, Harry has collaborated with esteemed professionals like Derek R. Buckle and Barrie C. Cantello. These partnerships have enhanced the depth of his research and contributed to the success of various projects, fostering a collaborative environment that drives innovation.

Conclusion

In conclusion, Harry Smith stands as a remarkable figure in the realm of innovation, with a strong focus on medical advancements through his numerous patents. His contributions to the field reflect a dedication to improving health outcomes, establishing him as a significant inventor in his area of expertise.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…